Kaiser to Look for Autism’s Causes in Large-Scale Study
By Victoria Colliver,
San Francisco Chronicle
| 03. 31. 2015
Untitled Document
Kaiser Permanente is about to begin what is believed to be the largest genetic research project ever conducted by a health organization into the causes of autism, gathering biological and other health information from 5,000 Northern California families who have a child with the developmental disorder.
Scientists have long suspected that autism results from a combination of genetics and environmental factors, but no one knows for sure. They hope a study of this size will reveal the root causes that could eventually lead to improved diagnoses and new treatments.
“This is an opportunity for the families who are affected by autism to really contribute their expertise and experience and help find answers,” said Lisa Croen, director of the autism program at Kaiser’s Division of Research in Oakland and the study’s principal investigator. “It’s definitely a huge scientific contribution in enhancing our understanding of autism, what causes it, how to treat it in the future and possibly even prevent it.”
Autism is a complex neurodevelopmental disorder characterized by a range of symptoms that include difficulties in communicating...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...